• COVID-19
  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Pharmacy | Medication Adherence Technology Services and Solutions | News, Analysis, Insights - HIT Consultant

NeuroFlow Secures $20M for Tech-Enabled Behavioral Health Integration Platform

by Fred Pennic 01/13/2021 Leave a Comment

NeuroFlow Secures $20M for Tech-Enabled Behavioral Health Integration Platform

What You Should Know: - NeuroFlow raises $20M to expand its technology-enabled behavioral health integration platform, led by Magellan Health. - NeuroFlow’s suite of HIPAA-compliant, cloud-based tools simplify remote patient monitoring, enable risk stratification, and facilitate collaborative care. With NeuroFlow, health care organizations can finally bridge the gap between mental and physical health in order to improve outcomes and reduce the cost of care. NeuroFlow, a
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Shields Health Solutions, ExceleraRx Announce Specialty Pharmacy Merger – M&A

by Jasmine Pennic 01/12/2021 Leave a Comment

Shields Health Solutions, ExceleraRx Announce Specialty Pharmacy Merger – M&A

What You Should Know: - Shields Health Solutions and Excelera announce a major specialty pharmacy merger that will form a combined company that consults with 700+ hospitals in 43 states, including Mass General Brigham, Yale New Haven, Intermountain Healthcare and Henry Ford. - The network of hospitals is designed to improve patient care through an infrastructure that helps with things like acquiring prior authorization for specialty drugs and staying adherent to them. It can also lower
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Why A Patient-First Strategy for Specialty Rx Pharmacists Is Critical to Optimize Outcomes

by Dr. Brandon Salke, PHARM.D, Pharmacist-in-charge, Optime Care 01/08/2021 Leave a Comment

Patient-First Strategy: Uses Specialty Rx Pharmacists to Maximize Orphan and Rare Disease Management, Optimize Patient Journey and Outcomes

Dr. Brandon Salke, PHARM.D, Pharmacist-in-charge, Optime Care One of the biggest challenges for biopharmaceutical companies of rare and orphan disease patient populations is optimizing disease management in a way that enhances the patient journey and improves outcomes. As these companies seek innovative solution partners, a patient-first approach that offers specialty Rx pharmacist expertise is critical for securing insurance coverage, coordinating care, ensuring compliance, and, ultimately,
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

2020’s Top 20 Digital Health M&A Deals Totaled $50B

by Fred Pennic 12/31/2020 Leave a Comment

2020’s Top 20 Digital Health M&A Deals Totaled $50B

Teladoc Health and Livongo Merge The combination of Teladoc Health and Livongo creates a global leader in consumer-centered virtual care. The combined company is positioned to execute quantified opportunities to drive revenue synergies of $100 million by the end of the second year following the close, reaching $500 million on a run-rate basis by 2025. Price: $18.5B in value based on each share of Livongo will be exchanged for 0.5920x shares of Teladoc Health plus cash consideration of
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Patient-First Model: High Tech Meets High Touch for Individuals with Rare Disorders

by Donovan Quill, President and CEO, Optime Care 12/30/2020 Leave a Comment

Patient-First Model: High Tech Meets High Touch to Optimize Data, Inform Health Care Decisions, Enhance Population Health Management for Individuals with Rare Disorders

Donovan Quill, President and CEO, Optime Care Industry experts state that orphan drugs will be a major trend to watch in the years ahead, accounting for almost 40% of the Food and Drug Administration approvals this year. This market has become more competitive in the past few years, increasing the potential for reduced costs and broader patient accessibility. Currently, these products are often expensive because they target specific conditions and cost on average $147,000
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

17 Recently Launched COVID-19 Vaccine Management Solutions to Know

by Fred Pennic 12/18/2020 Leave a Comment

16 COVID-19 Predictions and Trends for 2021 Executive Roundup 12-Available-COVID-19-Vaccine-Management-Solutions-to-Know-In-Depth-1

An in-depth look at twelve recently released COVID-19 vaccine management solutions as COVID-19 vaccines are being distributed nationwide. 1. Microsoft Microsoft launches a COVID-19 vaccine management platform with partners Accenture and Avanade, EY, and Mazik Global to help government and healthcare customers provide fair and equitable vaccine distribution, administration, and monitoring of vaccine delivery. Microsoft Consulting Services (MCS) has deployed over 230 emergency COVID-19
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Cerner, Banner Health, Xealth Partner to Simplify How Clinicians Prescribe Digital Health

by Jasmine Pennic 12/10/2020 Leave a Comment

Cerner, Banner Health, Xealth Partner to Simplify How Clinicians Prescribe Digital Health

What You Should Know: - Cerner Corporation today announced with Xealth new centralized digital ordering and monitoring for health systems, starting with Banner Health, to foster digital innovation. - Health systems can prescribe digital therapeutics, smartphones, and internet apps directly within the EHR to address areas such as chronic disease management, behavioral health, maternity care, and surgery prep. Cerner, today announced it’s building on the recent collaboration with
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Freespira Secures $10M for FDA-Cleared Digital Therapeutic to Eliminate Panic Attacks, PTSD Symptoms

by Jasmine Pennic 12/09/2020 Leave a Comment

Freespira Secures $10M for FDA-Cleared Digital Therapeutic to Eliminate Panic Attacks, PTSD Symptoms

What You Should Know: - Lightspeed Venture Partners, the VC behind Nest and GrubHub, is leading a $10 million round for Freespira, an FDA-cleared digital therapeutic proven to significantly reduce or eliminate panic attacks and PTSD symptoms by training users to normalize respiratory irregularities. - In 28 days, Freespira can reduce or eliminate panic attacks and PTSD symptoms from home with just a tablet, sensor, and custom app. There’s no medicine with possible side effects and no need
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

M&A: Ro Acquires On-Demand, In-Home Platform Workpath

by Fred Pennic 12/08/2020 Leave a Comment

M&A: Ro Acquires On-Demand, In-Home Platform Workpath

What You Should Know: - Ro announced it has acquired Workpath, a technology platform that powers on-demand, in-home healthcare and diagnostics services nationwide. - Through this acquisition, Ro’s platform will now uniquely bring together a patient's doctor, pharmacy, and diagnostics/lab--offering a personalized, end-to-end experience with no insurance required. - Ro is also announcing a partnership with Quest Diagnostics, which operates more than 2,200 locations nationwide, to
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

HHS Taps CVS Health for Pilot to Administer COVID-19 Therapy to Patients At Home & Long-Term Care Facilities

by Jasmine Pennic 12/02/2020 Leave a Comment

HHS Taps CVS Health for Pilot to Administer COVID-19 Therapy to Patients At Home & Long-Term Care Facilities

What You Should Know: - Today, CVS Health was selected by HHS, as part of Operation Warp Speed, to pilot the administration of a limited supply of bamlanivimab, a monoclonal antibody therapy, with eligible COVID-19 patients at-risk of severe infection or complications resulting from the virus. - Under this pilot, Coram, the specialty pharmacy and infusion care business of CVS Health, will administer the intravenous therapy in patients’ homes or long-term care facilities to help meet the
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]
  • 1
  • 2
  • 3
  • …
  • 17
  • Next Page

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Read

  • CVS Health Launches Senior Medical Alert System, Symphony CVS Health Launches Senior Medical Alert System, Symphony
  • 30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021 30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021
  • 20 COVID-19 Predictions and Trends for 2021 - Executive Roundup 20 COVID-19 Predictions and Trends for 2021 – Executive Roundup
  • 20 COVID-19 Predictions and Trends for 2021 - Executive Roundup MEDITECH Launches Quick Vaccination Solution to Streamline COVID-19 Vaccination Process
  • ONC Issues First Health IT Standards Bulletin Discussing USCDI & SVAP ONC Issues First Health IT Standards Bulletin Discussing USCDI & SVAP
  • 16 COVID-19 Predictions and Trends for 2021 Executive Roundup 12-Available-COVID-19-Vaccine-Management-Solutions-to-Know-In-Depth-1 17 Recently Launched COVID-19 Vaccine Management Solutions to Know
  • COVID-19 Deferrals Lead to 3 Major Conditions Payers/Providers Must Address in 2021 COVID-19 Deferrals Lead to 3 Major Conditions Payers/Providers Must Address in 2021
  • FDA Approves COVID-19 Oral Fluid Test for Use Nationwide In-Depth: 32 FDA-Approved COVID-19 Testing Kits
  • 5G in Healthcare: 7 Advantages & Disadvantages for Providers to Know 5G in Healthcare: 7 Advantages & Disadvantages for Providers to Know
  • Heritage Group Healthcare PE Firm Heritage Group Launches $300M Health Tech Fund

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2020 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2021. HIT Consultant Media. All Rights Reserved. Privacy Policy |